Deutsche Märkte geschlossen

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
103,29+3,02 (+3,01%)
Börsenschluss: 04:00PM EDT
103,01 -0,28 (-0,27%)
Nachbörse: 07:58PM EDT

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sektor(en)Healthcare
BrancheBiotechnology
Vollzeitmitarbeiter3.900

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Stephane BancelCEO & Director4,97M392,58M1973
Dr. Stephen Hoge M.D.Pres2,41M56,52M1976
Mr. James M. MockChief Financial Officer1,49MN/A1977
Ms. Arpa GarayChief Commercial Officer2,67MN/A1979
Dr. Jerh Collins Ph.D.Chief Technical Operations & Quality OfficerN/AN/A1966
Dr. Melissa J. Moore Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardN/AN/AN/A
Mr. Brad MillerChief Information OfficerN/AN/A1973
Ms. Lavina Talukdar CFASr. VP & Head of Investor RelationsN/AN/AN/A
Ms. Shannon Thyme KlingerChief Legal Officer & Corp. Sec.N/AN/A1971
Colleen HusseySr. Director of Corp. CommunicationsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Moderna, Inc.s ISS Governance QualityScore, Stand 28. September 2023, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 10, Shareholderrechte: 10, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.